Maruho Report 2021
25/58

23Springs businessMetal Components Japan, AsiaMachinery businessMedical-Related Machines Japan, the United States, EuropeMedical devices and components businessLess Invasive Medical Device & Components Japan, the United States, EuropeMaruho Hatsujyo Kogyo Co., Ltd.Maruho Hatsujyo Kogyo is currently engaged in the three key businesses of springs, medical devices and components, and machinery, providing appropriate products and services to satisfy the diverse needs of client companies. For the springs business, we have established a solid business base in Japan, while at the same time establishing “optimal location production” at Maruho Hatsujyo (Thailand) Co., Ltd. and PT. Maruho Hatsujyo Batam (Indonesia), thereby further developing and deepening our position in the global market. In the medical devices and components business, which we launched in full scale in 2013, we are working on high-value-added products used for minimally invasive In the fiscal year ended September 2021, the first year of our Third Medium-Term Plan, we endeavored to adapt ourselves to the “new normal” through digital transformation (DX) of Maruho Hatsujyo Kogyo’s own style in accordance with the principle of “lean & powerful.” By utilizing AI, the internet of things (IoT), and other advanced technologies, we will pursue four strategic goals: (1) integration of online and in-person services, (2) high-efficiency production, (3) technology development, and (4) lean, high-efficiency, and low-cost organizations and systems. In the springs business, we have been working to enhance our business base in Japan while expanding our presence in the Asian market. In the medical devices and components business, we are focusing efforts on expanding our business areas to new items such as stents and marker coils and enhancing  treatments, such as embolization coils and drive shafts. In the machinery business segment, we propose a variety of packaging solutions based mainly on Press Through Packaging (PTP) packaging machines for medical drugs, and we have an over 70% market share of small packaging machines in Japan.  In terms of financial performance, we have achieved steady progress according to the Third Medium-Term Plan started in October 2020. Net sales of the Maruho Hatsujyo Kogyo Group for the fiscal year ended September 2021 reached 9,676 million yen, an increase of 18.6% from the previous fiscal year.business in North America while endeavoring to reinforce our main items. In the machinery business, based on the “EAGLE small platform” developed by gathering Maruho Hatsujyo Kogyo’s technologies and know-how, we are working to not only expand sales for pharmaceutical purposes but also develop market in non-pharmaceutical fields.In the Third Medium-Term Plan, we set the targets of achieving an annual growth rate of 112% for the target period of the plan and net sales of 11.6 billion yen in the fiscal year ending September 2023, the final year of the plan. We strongly promote our overseas businesses and plan to make them profitable by the fiscal year ending September 2023.know-how based on technology to produce more compact machinesPrecision metal processing technology consultation Adopting to the “new normal” through DX

元のページ  ../index.html#25

このブックを見る